Nanyang Biologics Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
16
- Latest Deal Type
-
Reverse Merger
- (Announced)
- Latest Deal Amount
-
$1.5B
- Investors
-
2
Nanyang Biologics General Information
Description
NYB Holdings Ltd, along with its subsidiaries, is a pre-clinical biopharmaceutical company engaged in the research and development of therapeutics and nutraceuticals derived from biodiversity, including tropical medicinal plants with a history of traditional use. It focuses on discovering and developing natural compounds for applications in oncology and other chronic diseases, and also offers a consumer nutraceutical product line.
Contact Information
Website
nyb.groupCorporate Office
- Nanyang Avenue
- Singapore
- Singapore
Corporate Office
- Nanyang Avenue
- Singapore
- Singapore
Nanyang Biologics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Reverse Merger | 02-Oct-2025 | $1.5B | Announced | Generating Revenue | ||
| 2. Accelerator/Incubator | 03-Mar-2025 | Completed | Clinical Trials - Phase 1 | |||
| 1. University Spin-Out | 01-Jan-2020 | Completed | Startup |
Nanyang Biologics Signals
Nanyang Biologics Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| The Ignition AI Accelerator | Accelerator/Incubator | |||
| Nanyang Technological University | University |
Nanyang Biologics Acquisitions (1)
Nanyang Biologics’s most recent deal was a Merger/Acquisition with RF Acquisition II. The deal was made on 02-Oct-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| RF Acquisition II | 02-Oct-2025 | Merger/Acquisition | Special Purpose Acquisition Company (SPAC) |
Nanyang Biologics FAQs
-
When was Nanyang Biologics founded?
Nanyang Biologics was founded in 2020.
-
Where is Nanyang Biologics headquartered?
Nanyang Biologics is headquartered in Singapore, Singapore.
-
What is the size of Nanyang Biologics?
Nanyang Biologics has 16 total employees.
-
What industry is Nanyang Biologics in?
Nanyang Biologics’s primary industry is Drug Discovery.
-
Is Nanyang Biologics a private or public company?
Nanyang Biologics is a Private company.
-
What is the current valuation of Nanyang Biologics?
The current valuation of Nanyang Biologics is .
-
What is Nanyang Biologics’s current revenue?
The current revenue for Nanyang Biologics is .
-
Who are Nanyang Biologics’s investors?
The Ignition AI Accelerator and Nanyang Technological University have invested in Nanyang Biologics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process